par Blum, David 
;Hourez, Raphaël ;Galas, Marie-Christine ;Popoli, Patrizia;Schiffmann, Serge N.
Référence Lancet neurology, 2, 6, page (366-374)
Publication Publié, 2003-06
;Hourez, Raphaël ;Galas, Marie-Christine ;Popoli, Patrizia;Schiffmann, Serge N. Référence Lancet neurology, 2, 6, page (366-374)
Publication Publié, 2003-06
Article révisé par les pairs
| Titre: |
|
| Auteur: | Blum, David; Hourez, Raphaël; Galas, Marie-Christine; Popoli, Patrizia; Schiffmann, Serge N. |
| Informations sur la publication: | Lancet neurology, 2, 6, page (366-374) |
| Statut de publication: | Publié, 2003-06 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adenosine -- agonists |
| Adenosine -- antagonists & inhibitors | |
| Adenosine -- therapeutic use | |
| Animals | |
| Corpus Striatum -- metabolism | |
| Disease Models, Animal | |
| Humans | |
| Huntington Disease -- drug therapy | |
| Huntington Disease -- genetics | |
| Huntington Disease -- physiopathology | |
| Mitochondrial Diseases -- complications | |
| Mitochondrial Diseases -- drug therapy | |
| Mitochondrial Diseases -- metabolism | |
| Models, Molecular | |
| Models, Neurological | |
| Mutation | |
| Neural Networks (Computer) | |
| Neuroprotective Agents -- therapeutic use | |
| Receptor, Adenosine A1 -- agonists | |
| Receptor, Adenosine A1 -- physiology | |
| Receptor, Adenosine A2A -- antagonists & inhibitors | |
| Receptor, Adenosine A2A -- physiology | |
| Receptors, Dopamine -- metabolism | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1474-4422 |
| info:pii/S1474442203004113 | |
| info:pmid/12849153 |
